NMPA Approval

Levocetirizine Dihydrochloride Oral Solution

Approval Number

国药准字H20223535

Company扬子江药业集团江苏制药股份有限公司

Registration Date

July 26, 2022

Drug Information

Generic Name

盐酸左西替利嗪口服溶液

Dosage Form

口服溶液剂

Strength

0.05%（150ml:75mg）

Drug Type

化学药品

Registration Date

July 26, 2022

Company Information

Applicant Company

Company Name扬子江药业集团江苏制药股份有限公司

Company Address

江苏省泰州市高港区通江东路2号

Manufacturing Company

Company Name扬子江药业集团江苏制药股份有限公司

Company Address

江苏省泰州市高港区通江东路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服溶液 - NMPA 批准文号 | MedPath